1-21573653-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000478.6(ALPL):​c.863-12C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 1,608,524 control chromosomes in the GnomAD database, including 22,663 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3243 hom., cov: 31)
Exomes 𝑓: 0.14 ( 19420 hom. )

Consequence

ALPL
NM_000478.6 intron

Scores

2
Splicing: ADA: 0.0001207
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.362

Publications

10 publications found
Variant links:
Genes affected
ALPL (HGNC:438): (alkaline phosphatase, biomineralization associated) This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects. [provided by RefSeq, Oct 2015]
ALPL Gene-Disease associations (from GenCC):
  • adult hypophosphatasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
  • childhood hypophosphatasia
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, ClinGen, Orphanet
  • hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, G2P
  • infantile hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • odontohypophosphatasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • perinatal lethal hypophosphatasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 1-21573653-C-G is Benign according to our data. Variant chr1-21573653-C-G is described in ClinVar as Benign. ClinVar VariationId is 256234.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.433 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALPLNM_000478.6 linkc.863-12C>G intron_variant Intron 8 of 11 ENST00000374840.8 NP_000469.3 P05186-1A0A024RAB4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALPLENST00000374840.8 linkc.863-12C>G intron_variant Intron 8 of 11 1 NM_000478.6 ENSP00000363973.3 P05186-1

Frequencies

GnomAD3 genomes
AF:
0.188
AC:
28577
AN:
151668
Hom.:
3231
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.262
Gnomad AMI
AF:
0.118
Gnomad AMR
AF:
0.228
Gnomad ASJ
AF:
0.141
Gnomad EAS
AF:
0.446
Gnomad SAS
AF:
0.232
Gnomad FIN
AF:
0.191
Gnomad MID
AF:
0.118
Gnomad NFE
AF:
0.116
Gnomad OTH
AF:
0.184
GnomAD2 exomes
AF:
0.181
AC:
44850
AN:
247172
AF XY:
0.176
show subpopulations
Gnomad AFR exome
AF:
0.260
Gnomad AMR exome
AF:
0.248
Gnomad ASJ exome
AF:
0.134
Gnomad EAS exome
AF:
0.433
Gnomad FIN exome
AF:
0.182
Gnomad NFE exome
AF:
0.108
Gnomad OTH exome
AF:
0.155
GnomAD4 exome
AF:
0.144
AC:
209887
AN:
1456740
Hom.:
19420
Cov.:
33
AF XY:
0.145
AC XY:
104989
AN XY:
724640
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.276
AC:
9199
AN:
33310
American (AMR)
AF:
0.245
AC:
10837
AN:
44314
Ashkenazi Jewish (ASJ)
AF:
0.138
AC:
3590
AN:
26044
East Asian (EAS)
AF:
0.508
AC:
20055
AN:
39462
South Asian (SAS)
AF:
0.216
AC:
18505
AN:
85786
European-Finnish (FIN)
AF:
0.179
AC:
9482
AN:
53070
Middle Eastern (MID)
AF:
0.134
AC:
768
AN:
5722
European-Non Finnish (NFE)
AF:
0.115
AC:
127929
AN:
1108796
Other (OTH)
AF:
0.158
AC:
9522
AN:
60236
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.393
Heterozygous variant carriers
0
8261
16521
24782
33042
41303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5108
10216
15324
20432
25540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.189
AC:
28627
AN:
151784
Hom.:
3243
Cov.:
31
AF XY:
0.196
AC XY:
14525
AN XY:
74156
show subpopulations
African (AFR)
AF:
0.262
AC:
10841
AN:
41356
American (AMR)
AF:
0.228
AC:
3482
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.141
AC:
489
AN:
3468
East Asian (EAS)
AF:
0.448
AC:
2287
AN:
5106
South Asian (SAS)
AF:
0.232
AC:
1112
AN:
4798
European-Finnish (FIN)
AF:
0.191
AC:
2010
AN:
10540
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
292
European-Non Finnish (NFE)
AF:
0.116
AC:
7868
AN:
67952
Other (OTH)
AF:
0.188
AC:
396
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1079
2158
3236
4315
5394
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0929
Hom.:
176
Bravo
AF:
0.197
Asia WGS
AF:
0.327
AC:
1135
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Oct 17, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Infantile hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Adult hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Childhood hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypophosphatasia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.75
DANN
Benign
0.52
PhyloP100
-0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00012
dbscSNV1_RF
Benign
0.072
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75829132; hg19: chr1-21900146; COSMIC: COSV66376541; COSMIC: COSV66376541; API